Samuel L. Aitken, PharmD received his pharmacy degree from the University at Buffalo School of Pharmacy and Pharmaceutical Sciences in 2011. He completed his pharmacy practice residency at Yale-New New Haven Hospital and an infectious diseases pharmacotherapy fellowship at the University of Houston / Baylor St. Luke’s Medical Hospital, completing research in Clostridium difficile and Candida under Dr. Kevin Garey. He is currently a clinical pharmacy specialist in infectious diseases at MD Anderson Cancer Center with an active role in patient care and education of post-graduate pharmacy and medical trainees. His research is focused on the epidemiology, molecular mechanisms, and treatment of multidrug-resistant bacterial infections and C. difficile in patients with hematologic malignancy. Additionally, Dr. Aitken is the founding chair of the Antimicrobial Stewardship in Cancer Consortium (ASCC), a group dedicated to advancing antimicrobial stewardship research and practice in cancer patients.